Invivyd, Inc. SEC filings IVVD
Invivyd, Inc. has 448 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| S-3/A | Filing | Dec 19, 2025 | — |
| 424B5 | Prospectus supplement | Nov 19, 2025 | — |
| FWP | Free writing prospectus | Nov 17, 2025 | — |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| S-3 | Shelf registration | Oct 2, 2025 | — |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| FWP | Free writing prospectus | Aug 20, 2025 | — |
| 424B5 | Prospectus supplement | Aug 20, 2025 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| S-3 | Shelf registration | Feb 9, 2024 | — |
| 424B5 | Prospectus supplement | Dec 22, 2023 | — |
| S-3 | Shelf registration | Sep 28, 2022 | — |
| S-8 | Employee stock plan registration | May 13, 2022 | — |
| S-8 | Employee stock plan registration | Aug 23, 2021 | — |
| 424B4 | Prospectus | Aug 6, 2021 | — |
| S-1MEF | Filing | Aug 5, 2021 | — |
| S-1/A | Amended registration statement | Aug 4, 2021 | — |
| S-1/A | Amended registration statement | Aug 2, 2021 | — |
| S-1 | Registration statement | Jul 16, 2021 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IVVD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1832038
- Former names
- Adagio Therapeutics, Inc. (until Sep 12, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.